sam1933     2012survivalaid.com       

Overview

Stocks

Stats

Community

Widget

Last Activity: Removed FRE from bullish list on 09/15/10  Current Stock List: Symbol SP Sentiment Rating Return Since ENMD +207.08% 04/15/10 CTIC +5.26% 01/04/10 CYTR +194.78% 11/04/09 STEM +56.03% 10/30/09 XYNH N/A n/a 10/22/09 TELK N/A +64.57% 10/21/09 NNVC n/a 10/21/09 ACTC n/a 10/20/09 INIX N/A n/a 10/20/09 All-time Sectors of Interest ... View All > Opinion & Analysis application for pixantrone for the treatment   about CTIC   01/13/10 <font> Pixantrone Regulatory Strategy We are focusing on obtaining pixantrone approval based on the EXTEND (PIX301) phase III clinical trial of pixantrone for patients with relapsed or r... CytRx to Discuss Recent Progress at the Lippert/Hei..   about CYTR   12/11/09 CytRx to Discuss Recent Progress at the Lippert/Heilshorn & Associates Life Sciences Virtual Conference <!-- start story body --> LOS ANGELES--( BUSINESS WIRE )-- CytRx C... keep your eyes on xynh.. NEWS EXPECTED ANYTIME!!!   about XYNH   11/19/09 <table width="100%"> <tbody> <tr> <td> Xynergy has developed a working prototype of a product that converts traditional g... Advanced Cell Technology Files IND With FDA For Fir..   about ACTC   11/19/09   Advanced Cell Technology, Inc. ( OTCBB:ACTC ) announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phas... Coalition Against Loan Modification Fraud   about FRE   11/19/09 MCLEAN, Va., Nov 18, 2009 /PRNewswire-FirstCall via COMTEX/ -- The following statement was released today by Jeffery Markowitz, Vice President of Government and Industry Relations, Freddie Mac (NYSE: ...

Discussions

Re: 08/05/10
Please find another place to post your Spam

Re: 08/05/10
please find another place to post your Spam

Re: application for pixantrone for the treatment 08/05/10
spam

Re: Let's discuss ACTC 02/28/10
Advanced Cell Technology announced last week that due to its research in therapeutic cell types obtained from induced pluripotent stem cells (iPS) has been featured in several well known media outlets. The article states that iPS cells show abnormal expansion and early cellular aging, raising important questions about the future prospects for iPS cell-based therapies and supporting the use of A...

Re: 2010 : Year of the Black Swans From Hell 01/23/10
Thanks for your contribution. The Best, Sam

application for pixantrone for the treatment 01/13/10
Cell Therapeutics (CTIC ) reports>> the Food and Drug Administration's Oncologic Drugs Advisory Committee would review the company's new drug application for pixantrone for the treatment of relapsed/refractory aggressive non-Hodgkin's lymphoma on Feb. 10 .

Re: Ventana Biotech Inc. (VNTA) Enters Final Stage of Negoti... 01/04/10
Ventana-Sale of IP Update http://money.cnn.com/news/newsfeeds/articles/marketwire/0573201.htm I'll be much appreciated, sam1933@aol.com

Ventana Biotech Inc. (VNTA) Enters Final Stage of Negoti... 12/07/09
Ventana Enters Final Stage of Negotiations Monday 12/07/2009 8:27 AM ET - Market Wire Related Companies Symbol Last %Chg VNTA 0.12 20.00% As of 10:34 AM ET 12/7/09 Ventana Biotech Inc. ("Ventana") (PINK SHEETS: VNTA), a biotechnology company developing an appetite-suppressing and stress reducing chewing gum, today announced that it has entered into the final stages of negotiatio...

CytRx to Initiate Phase 2 Clinical Trial with INNO-206 in... 11/19/09
CytRx to Initiate Phase 2 Clinical Trial with INNO-206 in Patients with Advanced Gastric Cancer CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric (stomach) cancer. CytRx President a...

Meeting with FDA 11/19/09
StemCells, Inc. Provides Update on NCL Program Meeting with FDA StemCells, Inc. (NASDAQ: STEM) today provided an update on the ongoing clinical development program of its proprietary HuCNS-SC® product candidate (purified human neural stem cells) for neuronal ceroid lipofuscinosis (NCL), often referred to as Batten disease. On November 6, 2009, representatives of StemCells, Inc...




People Following sam1933 ...

Darth Vader Principal 77%

Leonora Piper Principal 80%

zhenhua Sr. Associate N/A

sam1933 is Following ...

mr.finviz Analyst 79%

Bradley Sugarman Sr. Analyst 78%

ricky Associate 77%

Friends of sam1933 ...

Mike Havrilla Principal 73%

dogcrap Sr. Associate 69%

Leonora Piper Principal 80%